+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Harvesting - Global Market Trajectory & Analytics

  • ID: 4804663
  • Report
  • February 2022
  • Region: Global
  • 306 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • ADS Biotec Inc.
  • Argos Technologies Inc.
  • Arthrex, Inc.
  • Avita Medical
  • Bertin Bioreagent
  • BRAND GMBH + CO KG

Global Cell Harvesting Market to Reach $359.2 Million by 2026


Cell harvesting is a next-generation technique that involves collection of stem cells from the culture media for R&D and therapeutic applications. Growth in the global market is spurred by of increasing investments in clinical, cell-based and regenerative medicine research. The technique is likely to gain from rising incidence of infectious and chronic diseases coupled with continuous expansion of the biotechnology and biopharmaceutical industries. Stem cell research is estimated to witness fastest growth as stem cells derived from the bone marrow hold potential to advance stem cell biology, regenerative medicine and stem cell-based therapies. Stem cells are one of the latest entrants joining the race for COVID-19 cure. The therapy involves intravenous administration of MSCs derived from the human placenta to COVID-19 patients for boosting the immune response and helping the body in fighting the infection. The approach is being investigated by various researchers in the US and China, with some of them observing positive outcomes.

Amid the COVID-19 crisis, the global market for Cell Harvesting estimated at US$233.2 Million in the year 2020, is projected to reach a revised size of US$359.2 Million by 2026, growing at a CAGR of 7.3% over the analysis period. Manual, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$284.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Automated segment is readjusted to a revised 5.6% CAGR for the next 7-year period. The Manual segment dominates market share owing to extensive adoption of these systems as a result of their affordable and user-friendly nature.



The U.S. Market is Estimated at $78.8 Million in 2021, While China is Forecast to Reach $32.1 Million by 2026


The Cell Harvesting market in the U.S. is estimated at US$78.8 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$32.1 Million by the year 2026 trailing a CAGR of 10.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR. The US dominates market share due to increasing R&D investments and favorable government policies. The US FDA has approved cord blood-based blood-forming stem cells for use in the US. These cells along with stem cells derived from the bone marrow are widely used in medical transplant procedures for treatment of cancer along with diseases related to the immune system and blood. The Asia-Pacific market expansion is being driven by increasing R&D spending to develop new treatments, government policies favoring stem cell research, and public-private efforts to foster stem cell-based treatments.

Select Competitors (Total 30 Featured) -

  • ADS Biotec Inc.
  • Argos Technologies Inc.
  • Arthrex, Inc.
  • Avita Medical
  • Bertin Bioreagent
  • BRAND GMBH + CO KG
  • Biomedical Research & Development Laboratories Inc. (Brandel)
  • (USA)
  • Connectorate AG
  • Cox Scientific Ltd
  • PerkinElmer Inc.
  • SP Industries
  • Terumo BCT Inc.
  • TOMTEC Imaging Systems GmbH
Frequently Asked Questions about the Global Market for Cell Harvesting

What is the estimated value of the Global Market for Cell Harvesting?

The Global Market for Cell Harvesting was estimated to be valued at $233.2 Million in 2020.

What is the growth rate of the Global Market for Cell Harvesting?

The growth rate of the Global Market for Cell Harvesting is 7.5%, with an estimated value of $359.2 Million by 2026.

What is the forecasted size of the Global Market for Cell Harvesting?

The Global Market for Cell Harvesting is estimated to be worth $359.2 Million by 2026.

Who are the key companies in the Global Market for Cell Harvesting?

Key companies in the Global Market for Cell Harvesting include ADS Biotec Inc., Argos Technologies Inc., Arthrex, Inc., Avita Medical, Bertin Bioreagent, BRAND GMBH + CO KG, Biomedical Research & Development Laboratories Inc. (Brandel), (USA) and Cox Scientific Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ADS Biotec Inc.
  • Argos Technologies Inc.
  • Arthrex, Inc.
  • Avita Medical
  • Bertin Bioreagent
  • BRAND GMBH + CO KG

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Cell Harvesting - A Prelude
  • With Stem Cells Holding Potential to Emerge as Savior for Healthcare System Struggling with COVID-19 Crisis, Demand for Cell Harvesting to Grow
  • Select Clinical Trials in Progress for MSCs in the Treatment of COVID-19
  • Lack of Antiviral Therapy Brings Spotlight on MSCs as Potential Option to Treat Severe Cases of COVID-19
  • Stem Cells Garner Significant Attention amid COVID-19 Crisis
  • Cell Harvesting - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Growing R&D Investments & Rising Incidence of Chronic Diseases to Drive the Global Cell Harvesting Market over the Long-term
  • US Dominates the Global Market, Asia-Pacific to Experience Lucrative Growth Rate
  • Biopharmaceutical & Biotechnology Firms to Remain Key End-User
  • Remarkable Progress in Stem Cell Research Unleashes Unlimited Avenues for Regenerative Medicine and Drug Development
  • Drug Development
  • Therapeutic Potential
  • A Prelude to Genetic Testing

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Development of Regenerative Medicine Accelerates Demand for Cell Harvesting
  • The Use of Mesenchymal Stem Cells in Regenerative Medicine to Drive the Cell Harvesting Market
  • Rise in Volume of Orthopedic Procedures Boosts Prospects for Stem Cell, Driving the Cell Harvesting
  • Global Orthopedic Surgical Procedure Volume (2010-2020) (in Million)
  • Increasing Demand for Stem Cell Based Bone Grafts: Promising Growth Ahead for Cell Harvesting
  • Spectacular Advances in Stem Cell R&D Open New Horizons for Regenerative Medicine
  • Global Regenerative Medicines Market by Category (2019): Percentage Breakdown for Biomaterials, Stem Cell Therapies and Tissue Engineering
  • Stem Cell Transplants Drive the Demand for Cell Harvesting
  • Rise in Number of Hematopoietic Stem Cell Transplantation Procedures Propels Market Expansion
  • Growing Incidence of Chronic Diseases to Boost the Demand for Cell Harvesting
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Rising Diabetes Prevalence Presents Opportunity for Cell Harvesting: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
  • Ageing Demographics to Drive Demand for Stem Cell Banking
  • Global Aging Population Statistics - Opportunity Indicators
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
  • Life Expectancy for Select Countries in Number of Years: 2019
  • High Cell Density as Major Bottleneck Leads to Innovative Cell Harvesting Methods
  • Advanced Harvesting Systems to Overcome Centrifugation Issues
  • Sophisticated Filters for Filtration Challenges
  • Innovations in Closed Systems Boost Efficiency & Productivity of Cell Harvesting
  • Enhanced Harvesting and Separation of Micro-Carrier Beads

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Increasing Research on Stem Cells for Treating COVID-19 to drive the Cell Harvesting Market
  • Rising Investments in Stem Cell-based Research Favors Cell Harvesting Market
  • Stem Cell Research Funding in the US (in US$ Million) for the Years 2011 through 2017
  • A Strong Regenerative Medicine Market Drives Cell Harvesting Demand
  • Arthritis
  • Percentage of Population Diagnosed with Arthritis by Age Group
  • Rapidly Ageing Population: A Major Driving Demand for Cell Harvesting Market
  • North American Elderly Population by Age Group (1975-2050)
  • Increasing Incidence of Chronic Diseases Drives Focus onto Cell Harvesting
  • CVD in the US: Cardiovascular Disease* Prevalence in Adults by Gender & Age Group
  • Rising Cancer Cases Spur Growth in Cell Harvesting Market
  • Estimated Number of New Cancer Cases and Deaths in the US (2019)
  • Estimated New Cases of Blood Cancers in the US (2020) - Lymphoma, Leukemia, Myeloma
  • Estimated New Cases of Leukemia in the US: 2020

CANADA

  • Number of New Cancer Cases in Canada: 2019

JAPAN

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Increasing Demand for Regenerative Medicine in Geriatric Healthcare and Cancer Care to Drive Demand for Cell Harvesting
  • Cancer Related Incidence and Deaths by Site in Japan: 2018

CHINA

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Rising Incidence of Cancer Drives Cell Harvesting Market
  • Number of New Cancer Cases Diagnosed (in Thousands) in China: 2018

EUROPE

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Cancer in Europe: Key Statistics
  • Cancer Incidence in Europe: Number of New Cancer Cases (in Thousands) by Site for 2018
  • Ageing Population to Drive Demand for Cell Harvesting Market

FRANCE

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

REST OF EUROPE

ASIA-PACIFIC

  • Cell Harvesting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 30
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • ADS Biotec Inc.
  • Argos Technologies Inc.
  • Arthrex, Inc.
  • Avita Medical
  • Bertin Bioreagent
  • BRAND GMBH + CO KG
  • Biomedical Research & Development Laboratories Inc. (Brandel)
  • (USA)
  • Connectorate AG
  • Cox Scientific Ltd
  • PerkinElmer Inc.
  • SP Industries
  • Terumo BCT Inc.
  • TOMTEC Imaging Systems GmbH
Note: Product cover images may vary from those shown